首页> 外文OA文献 >8. Monitoring of minimal residual disease (MRD) and hematopoietic chimerism with several complementary genetic methods in children treated with adoptive immunotherapy for post-transplant hematological CML relapse

【2h】

8. Monitoring of minimal residual disease (MRD) and hematopoietic chimerism with several complementary genetic methods in children treated with adoptive immunotherapy for post-transplant hematological CML relapse

机译：8.采用过继免疫疗法治疗移植后血液学CML复发的儿童，采用几种补充遗传方法监测最小残留病（MRD）和造血嵌合体

页面导航

著录项
相似文献
相关主题

著录项

作者
Ładoń D.; Jółkowska J.; Wojda A.; Pieczonka A.; Boruczkowski D.; Leda M.; Wachowiak J.; Witt M.;
展开▼
作者单位

展开▼
年度 2001
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. FISH与RQ-PCR监测慢性髓系白血病患者造血干细胞移植后微小残留病 [J] . 朱红倩, 刘晓力, 宋兰林, 癌症（英文版） . 2010,第002期
2. Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy. [J] . Formankova R, Honzatkova L, Moravcova J, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2000,第4期

机译：使用混合嵌合体和残留疾病检测以及过继免疫疗法对慢性粒细胞白血病患者移植后复发的预测和逆转。
3. Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience [J] . Bader Peter, Rettinger Eva, Merker Michael, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：基于移植后嵌合和MRD监测的抢先式免疫疗法是预防ALL异基因干细胞移植后复发的有效策略：单中心经验
4. Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia. [J] . Formankova R, Honzatkova L, Sieglova Z, Bone marrow transplantation . 2000,第4期

机译：对采用过继免疫疗法治疗的儿童的骨髓造血嵌合症的详细监测，以了解BMT后急性髓细胞白血病的高复发风险。
5. ELEVATION OF MINIMAL RESIDUAL DISEASE (MRD) IN THE PERIPHERAL BLOOD PRIOR TO THE CLINICAL RELAPSE IN DOGS WITH LYMPHOMA THAT ACHIEVED COMPLETE REMISSION AFTER CHEMOTHERAPY [C] . Masahiko Sato, Junpei Yamazaki, Yuko Goto-Koshino, Annual Conference of the Veterinary Cancer Society . 2009

机译：在淋巴瘤患者临床复发之前在外周血中的最小残留疾病（MRD）升高，从而在化疗后取得完全缓解
6. Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study) [O] . Koji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, 2013

机译：监测最小残留疾病（MRD）有助于预测成年Ph阴性ALL患者的预后：一项前瞻性研究的结果（ALL MRD2002研究）
7. Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring Is an Effective Strategy to Prevent Relapse after Allogeneic Stem Cell Transplantation in Children with ALL: A Single Center Experience [O] . Bader Peter, Rettinger Eva, Merker Michael, 2015

机译：基于移植后嵌合体和MRD监测的抢先式免疫疗法是预防ALL儿童异体干细胞移植后复发的有效策略：单中心经验

8. Monitoring of minimal residual disease (MRD) and hematopoietic chimerism with several complementary genetic methods in children treated with adoptive immunotherapy for post-transplant hematological CML relapse

著录项

相似文献

相关主题

期刊订阅